the co-administration of bispecific antibodies and car t-cells in cll: an in vivo study
Published 2 days ago • 31 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:25
prognostic and predictive biomarkers in cll and their potential in guiding treatment decisions
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
2:08
cll in taiwan: prevalence, pathogenesis, and clinical practice
-
41:49
webinar - safety cases and verification - what is a safety case?
-
1:30
xport-mf-044 trial: evaluating selinexor in jak inhibitor-naïve mf and moderate thrombocytopenia
-
35:20
webinar - safety cases and verification - identifying and managing safety critical equipment
-
25:01
what are the four different types of medical device risk analysis?
-
42:19
iso 35001:2019, by dr. miguel martin n. moreno ii (md, cbp, ifba pc, lssyg)
-
3:38
short term safety
-
6:21
healthcare module how-to: patient safety
-
31:33
biorisks management – standards, risks and oversight
-
![[safety] s10](https://i.ytimg.com/vi/fCiP-WsJ9Nw/mqdefault.jpg)
31:16
[safety] s10
-
1:08:43
topic1 safety and quality assurance
-
3:23
risk factors & prevention of advanced cscc
-
0:52
vlad naidzionak, md — hematology/oncology
-
4:36
haemonetics
-
39:23
nacfc 2020 | discipline group 21: epi/biostat
-
![[safety] s8](https://i.ytimg.com/vi/0-UPlD9wIy0/mqdefault.jpg)
55:26
[safety] s8